Patents by Inventor NUVO RESEARCH INC.

NUVO RESEARCH INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140113970
    Abstract: The invention provides systems and methods for controlled dispensing of topical analgesics contained in a metered dispensing system. The systems and method are useful for treating signs and symptoms of osteoarthritis. The method includes depressing a hand pump to dispense a dose of a topical pain reliever in a viscous solution from the hand pump, wherein the hand pump is configured to dispense the dose within a tolerance specified by a corresponding label approved by a government regulatory agency; and spreading the topical solution on skin.
    Type: Application
    Filed: October 22, 2012
    Publication date: April 24, 2014
    Applicants: Mallinckrodt LLC Covidien, Nuvo Research Inc.
    Inventors: Nuvo Research Inc., Mallinckrodt LLC
  • Publication number: 20130337031
    Abstract: The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a local anesthetic, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.
    Type: Application
    Filed: March 8, 2013
    Publication date: December 19, 2013
    Applicant: Nuvo Research Inc.
    Inventor: Nuvo Research Inc.
  • Publication number: 20130079404
    Abstract: It has been discovered that certain combinations of compounds are excellent penetration enhancers and, as such, can be incorporated in a topical formulation to facilitate administration of active agents. The increased penetration enhancement can also lead to a reduction in the total concentration of skin irritants in the formulation. There is described herein a topical formulation comprising (i) an active agent selected from at least one of lidocaine and tetracaine; (ii) a first compound, and (iii) a second compound, wherein the first compound and second compound are different, and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate.
    Type: Application
    Filed: November 19, 2012
    Publication date: March 28, 2013
    Applicant: Nuvo Research Inc.
    Inventor: Nuvo Research Inc.
  • Publication number: 20130065870
    Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
    Type: Application
    Filed: October 31, 2012
    Publication date: March 14, 2013
    Applicant: Nuvo Research Inc.
    Inventor: Nuvo Research Inc.
  • Publication number: 20130059915
    Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
    Type: Application
    Filed: November 2, 2012
    Publication date: March 7, 2013
    Applicant: NUVO RESEARCH INC.
    Inventor: NUVO RESEARCH INC.